Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9840702 CRISPR-based compositions and methods of use

Patent 9840702 was granted and assigned to Integrated DNA Technologies on December, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Integrated DNA Technologies
Integrated DNA Technologies
0
Date Filed
December 18, 2015
0
Date of Patent
December 12, 2017
0
Patent Application Number
14975709
0
Patent Citations Received
‌
US Patent 12084663 Incorporation of unnatural amino acids into proteins using base editing
0
‌
US Patent 11661590 Programmable CAS9-recombinase fusion proteins and uses thereof
0
‌
US Patent 11702651 Adenosine nucleobase editors and uses thereof
0
‌
US Patent 12012433 Expression and purification of Cas enzymes
0
‌
US Patent 11866726 Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
0
‌
US Patent 11932667 Expression and purification of Cas enzymes
0
‌
US Patent 11912985 Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
0
‌
US Patent 11932884 High efficiency base editors comprising Gam
0
‌
US Patent 11965185 None
0
‌
US Patent 11999947 Adenosine nucleobase editors and uses thereof
0
•••
Patent Inventor Names
Mark Aaron Behlke
0
Ashley Mae Jacobi
0
Garrett Richard Rettig
0
Michael Allen Collingwood
0
Mollie Sue Schubert
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9840702
0
Patent Primary Examiner
‌
Addison D Ault
0

Find more entities like US Patent 9840702 CRISPR-based compositions and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.